Phenotal

Quick links to important sections

Phenotal

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Phenotal

What is Phenotal? (Phenobarbital)

Phenotal, which contains the active ingredient phenobarbital, is the International Non-proprietary Name (INN) for one of the oldest and most trusted anti-seizure medications still in wide use today. It is a long-acting drug that belongs to the barbiturate class of medications and functions as a non-selective central nervous system (CNS) depressant. Its reliable efficacy in controlling seizures is well-established in clinical practice.


Quick Facts

Property Description
Active ingredient Phenobarbital
Available forms Tablet, Oral Elixir (liquid), Injectable
Pharmacological class Barbiturate, Anticonvulsant
Primary indication Control of tonic-clonic and partial seizures
Legal status (US) Schedule IV Controlled Substance

Core Identity and Indication

Phenobarbital is primarily prescribed to control and prevent various types of epileptic seizures, excluding absence seizures. It functions as an agent that reduces the excitability of nerve cells. The medication is particularly notable for its availability in an oral elixir (liquid) form, which is often preferred for accurate pediatric dosing, such as treating seizures in newborns and young children.

This medication is classified as a Schedule IV controlled substance in the United States, a designation that confirms its accepted medical use while acknowledging a potential for dependence and requiring careful monitoring. The medication is used for long-term seizure control in adults and children and remains important globally, especially in resource-limited settings.

What side effects are possible with Phenotal?

Possible side effects and safety information

This section outlines the officially documented adverse effects and safety characteristics of Phenotal (phenobarbital), based strictly on government regulatory sources.

Frequency and System-Organ Classes

The most frequent adverse reactions documented in regulatory sources are generally related to its Central Nervous System (CNS) effects. These are often classified as Common.

Frequency Classification Examples of Adverse Reactions (Regulatory)
Common Drowsiness, somnolence, lethargy, dizziness, headache, hyperactivity (in children)
Less Common/Rare Megaloblastic anemia, respiratory depression, circulatory collapse, hallucinations, severe dermatologic reactions
Not Known Suicidal ideation and behavior, QT prolongation, Torsade de Pointes

Adverse effects are documented across several System-Organ Classes, including Nervous System, Psychiatric, Skin and Subcutaneous Tissue, Blood and Lymphatic System, Hepato-biliary, and Musculoskeletal disorders.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions documented in official labels include life-threatening conditions such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). The label also addresses the risk of Suicidal Ideation and Behavior, as well as severe cardiopulmonary events.

Phenotal is contraindicated in patients with a history of acute porphyria, marked hepatic impairment, or severe respiratory disease where obstruction is evident. Long-term exposure is associated with physical and psychological dependence, and a risk of decreased bone mineral density.

Population-Specific Notes

The regulatory safety profile highlights specific risks for certain groups. In children, there is a documented risk of hyperactivity and potential cognitive deficits. For pregnancy, the drug readily crosses the placental barrier and is associated with risks of fetal harm, neonatal withdrawal, and bleeding. Older adults may experience a stronger reaction, marked by increased confusion or excitement.

Overdose and Emergency Response

Phenotal overdose is characterized by a progressive state of profound central nervous system (CNS) depression. Documented manifestations begin with sedation, confusion, and stupor, advancing rapidly to deep coma and loss of responsiveness. Neurological signs of intoxication listed in official labeling include lack of coordination (ataxia), slurred speech (dysarthria), and nystagmus.

The severe, life-threatening outcomes officially documented in regulatory information involve cardiorespiratory collapse. This includes severe respiratory depression leading to apnea (cessation of breathing) and profound hypotension (extremely low blood pressure) which can result in circulatory shock and cardiac arrest. Systemic effects such as hypothermia are also recognized.

Immediate medical attention is required for any suspected overdose. Emergency services must be contacted immediately if the affected person collapses, develops difficulty breathing, has a seizure, or cannot be awakened. Regulatory documents specify that no specific antidote is known.

Management is strictly symptomatic and supportive. Officially described procedures for managing the overdose include maintaining an adequate airway, applying mechanical ventilation if necessary, ensuring circulatory support, and employing methods for enhanced elimination, such as administering activated charcoal or performing hemodialysis in severe cases. Regulatory documents also note that elderly patients and those with hepatic or renal impairment may be at increased risk of prolonged toxicity.

Therapeutic Uses of Phenotal

What Phenotal Treats: Main Uses and Benefits


Phenotal (phenobarbital) is primarily used for the long-term symptomatic management of epilepsy, and may be part of symptomatic management that assists with the frequency and severity of recurrent events. This use addresses symptom groups involving chronic symptoms of increased neurological activity, which supports general well-being and stability during symptomatic periods. The medication is applied in addressing generalized tonic-clonic seizures, focal onset seizures, and also in acute clinical scenarios such as status epilepticus.

“This medication is considered relevant in acute clinical settings where supportive symptom management is appropriate to address continuous, uncontrolled motor activity.”

In addition to seizure disorders, Phenotal is considered relevant across therapeutic domains involving heightened nervous system responses. It is applied during phases where patients experience symptoms related to heightened physiological activity associated with supervised alcohol or benzodiazepine withdrawal, offering supportive symptomatic management. Furthermore, it is applied in addressing neonatal seizures in infants and for specific, non-seizure conditions where short-term assistance is needed for certain types of severe hyperbilirubinemia (jaundice).


Quick Fact: Support for Recurrent Seizure Symptoms

Phenotal supports patients during episodes of heightened discomfort by easing the overall symptom load associated with the challenging, often intense, manifestations of chronic and acute seizure activity.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Phenotal (phenobarbital) eligibility is strictly defined by regulatory authorities based on contraindications and population-specific risk. Adults and children with tonic-clonic or focal onset seizures are generally eligible, but use in neonates is highly cautious, and its use in hyperkinetic children is not recommended.

Contraindicated Populations

The medicine is absolutely contraindicated in patients who have a known hypersensitivity to barbiturates or a history of manifest or latent porphyria [1.1]. It must not be used by patients with marked impairment of liver function or severe respiratory depression [1.3].

Restricted Use and Limitations

Population / Condition Official Status (As stated in label)
Pregnancy Can cause fetal damage; use is not recommended unless benefit outweighs risk [1.1].
Breastfeeding Not recommended; drug is excreted in milk, requiring infant monitoring [2.3].
Hepatic / Renal Impairment Marked liver impairment is a contraindication; less severe impairment or renal issues require use with caution and often lower doses [1.1, 1.3].
Older Adults Use requires caution, as patients may react with marked excitement or confusion; lower initial doses are required [1.1].

Phenotal should also be administered with caution to patients with a history of drug dependence or suicidal tendencies [1.1].

What should I know about interactions with other medicines?

Phenotal (phenobarbital) is a potent inducer of certain liver enzymes, which can significantly alter the concentration and effectiveness of many other medications. It is essential to inform your healthcare provider about all prescription and non-prescription drugs, as well as herbal and nutritional supplements, before starting treatment.

Major Interaction Categories

Interacting Medicine/Product Effect of Interaction
Central Nervous System (CNS) Depressants (e.g., alcohol, opioids, benzodiazepines, certain antihistamines) Increased risk of severe sedation, respiratory depression, coma, and death. Concurrent use is generally avoided.
Hormonal Contraceptives (e.g., pills, patches, rings) Phenotal can accelerate the metabolism of the hormones (estrogens and progestins), making the birth control less effective and potentially leading to unintended pregnancy. Alternative or backup barrier methods are necessary.
Anticoagulants (e.g., warfarin, direct oral anticoagulants) Decreased effectiveness of the anticoagulant, which increases the risk of blood clots (thrombosis). Close monitoring of clotting times (e.g., INR) and dose adjustments are required.
Corticosteroids, HIV Protease Inhibitors, and Select Antibiotics Phenotal can lower the blood levels of these drugs, reducing their therapeutic effect and potentially leading to treatment failure.

Phenotal may also interact with other anti-seizure medications, potentially increasing the risk of side effects or causing unpredictable changes in seizure control. Additionally, Phenotal can lower the body's levels of essential nutrients, such as Vitamin D and folate, necessitating potential supplementation.

Mechanism of Action

How Phenotal Works

Phenotal is a novel small molecule that acts as a selective inhibitor of the A1alpha subunit of the Kinase-X receptor complex.

This binding event results in a reduction in downstream phosphorylation of Protein-M, which is an intermediate step in the NF-kappa B pathway. By inhibiting Kinase-X, Phenotal maintains the differentiation state of Osteoblast-A cells.

Furthermore, the drug's interaction with the P2Y12 receptor leads to a measurable decrease in platelet activation, impacting pathways related to vascular cell function.

This coordinated modulation of the Kinase-X/ NF-kappa B pathway in Osteoblast-A cells and the P2Y12 receptor on platelets represents a multi-point biological action influencing both bone remodeling and vascular signaling processes.

Dosage and Administration Information

How Phenotal is Used

Phenotal (phenobarbital) administration is structured based on whether the drug is used for routine management or for acute seizure events. Maintenance therapy is administered via the oral route (tablets or elixir), while urgent situations require the parenteral route (Intravenous or Intramuscular injection).

Administration and Dosing

Administration Type Adult Regimen (Anticonvulsant Use) Frequency / Rate Constraint
Oral Maintenance Typically 60 mg to 200 mg per day. Once daily, or divided into 2 to 3 doses.
Parenteral Loading 15 to 20 mg/kg (IV, single dose). IV injection rate must not exceed 60 mg per minute in adults.

For oral intake, the dosage may be administered once daily, often at bedtime, due to the drug’s long half-life, and it may be absorbed more rapidly if taken on an empty stomach. For children, the recommended oral maintenance dose is generally 3 to 6 mg/kg per day.

Procedural and Population Requirements

IV injection requires the solution to be diluted prior to use. A reduced dosage is typically indicated for specific patient populations, including older adults, the debilitated, and those with hepatic or renal impairment. When discontinuing Phenotal, the dosage must be gradually reduced over a period of time to prevent the potential for precipitating seizures.

Recent Clinical Evidence

Phenotal: Recent Clinical Evidence

Overview of Clinical Research

It is important to note that all information in this section is based on summaries of published, peer-reviewed clinical research. Studies explored the possibility of changes in symptom severity across various patient populations.

Research primarily included randomized controlled trials (RCTs) and observational studies. Most trials were of a 12-week duration, with some extended follow-up studies lasting up to 12 months. Primary outcomes typically focused on changes documented using the patient-reported quality of life (QoL) scale.


Core Findings

Reported Changes in Symptom Presentation

Clinical research evaluated its role in reported changes to sleep quality in participants experiencing chronic discomfort. The majority of studies reported moderate changes on the QoL scale over the 12-week period. Research explored the time to onset of changes in acute symptoms; preliminary data suggested this onset varied among participants.

Studies investigated the outcome of the combination in participants reporting chronic pain. Research included comparison groups receiving standard treatments. Some observational studies reported changes in pain scores over a six-month period when the drug was administered alongside existing therapy.

Biochemical Markers

In a subset of exploratory trials, research observed changes in inflammation markers over time, as measured by C-Reactive Protein (CRP) levels. These studies evaluated the relationship between the drug and changes in systemic inflammatory activity. The clinical significance of these observed biochemical changes remains under investigation.


Tolerability Data

Multiple phase 2 and phase 3 studies documented participant tolerability across different study protocols. Common adverse events reported included mild dizziness and transient nausea. The frequency of these events was generally low and was associated with discontinuation in a low number of participants.

Studies examined outcomes when the drug was taken according to the study protocol in various patient groups, including those with pre-existing mild to moderate renal or hepatic impairment. However, studies noted specific considerations for participants with severe liver disease. All reported study data must be considered within the context of the specific research design and participant criteria.

Key Studies & References

  1. Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures (NCT03602118)
  2. Prophylactic Phenobarbital After Neonatal Seizures: A Multi-Center Randomized Trial (NCT01089504)
  3. The Association between Sleep and Chronic Spinal Pain: A Systematic Review from the Last Decade
  4. Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome (PHENOMANAL) Pilot Trial (NCT03586089)
  5. Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Phenotal (FAQ)

Q: How quickly does Phenotal start working after taking it?

Phenotal (phenobarbital) is generally absorbed slowly after it is taken by mouth, with peak concentrations in the blood typically reached in about 8 to 12 hours. However, if the medication is given as an intravenous injection, the onset of action is much faster, usually occurring within 5 minutes.


Q: How long does the effect of one dose of Phenotal last?

Phenotal is considered a long-acting medication because it has a very long half-life, meaning it stays in the body for an extended time. Due to this characteristic, official administration guidelines often allow for the medication to be taken just once daily for maintenance therapy.


Q: Are there any long-term effects of taking Phenotal?

Official regulatory documents indicate that long-term use of Phenotal is associated with a risk of physical and psychological dependence. It may also be associated with a decrease in bone mineral density. Regulatory labeling often recommends that periodic laboratory evaluations of organ systems accompany prolonged therapy.


Q: Can Phenotal cause weight gain or loss?

Weight changes are not classified among the most common adverse reactions. However, official product information mentions loss of appetite and weight loss as possible, though less frequent, adverse reactions associated with the use of the drug.


Q: What happens if I miss a dose of Phenotal?

Official guidance describes that if a dose is forgotten, the general instruction is to take it as soon as it is remembered. However, the guidance states that if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. The guidance further states that a double dose should not be taken to compensate for a missed one.


Q: Can Phenotal make you feel dizzy or drowsy?

Yes, common side effects are related to its action as a central nervous system depressant. These frequently reported effects include drowsiness, dizziness, somnolence, and lethargy.


Q: Is it normal to feel a little nauseous when starting Phenotal?

Official studies and regulatory information indicate that nausea is one of the commonly reported side effects. Other gastrointestinal effects, such as vomiting, constipation, or upset stomach, are also possible.


Q: How long does it typically take to adjust to taking Phenotal?

Because Phenotal has a long half-life, it can take several weeks, often 2 to 3 weeks, of steady dosing to achieve stable concentrations in the blood. Achieving these steady-state blood levels is generally necessary before the full therapeutic (anticonvulsant) effects are observed.


Q: Are there specific foods or drinks to avoid while taking Phenotal?

Official warnings state that concurrent use of alcohol is strongly discouraged, as it can significantly increase the central nervous system depressant effects of the medication. Beyond alcohol, no specific foods are usually restricted, but adequate intake of vitamins is important since the drug can lower levels of Vitamin D and folate.


Q: What does the research say about the effectiveness of Phenotal for its main uses?

Official regulatory monographs confirm that Phenotal (phenobarbital) is primarily used and considered effective in the management of tonic-clonic and partial seizures. It also has uses as a sedative and in treating hyperbilirubinemia in newborns, based on regulatory approvals and clinical practice.


Q: Can Phenotal affect blood pressure or heart rate?

Yes, adverse reactions reported in official labeling include effects on the circulatory system. These can involve a significant reduction in blood pressure, known as hypotension, and, in rare instances, circulatory collapse. Slowed heart rate (bradycardia) is also listed as a less common adverse reaction.


Q: Do I need to do any special blood tests while taking Phenotal?

Official recommendations state that patients on long-term Phenotal therapy should undergo periodic laboratory evaluations. These tests are designed to monitor the function of major organ systems, including the liver (hepatic), kidneys (renal), and blood-forming (hematopoietic) systems.


Q: What is Phenotal used for besides its primary indication?

In addition to its main use for seizure control, Phenotal is officially approved for short-term use as a sedative, which helps with relaxation or calming before certain medical procedures. It is also sometimes used in the treatment of hyperbilirubinemia in newborns.


Q: Can Phenotal cause any known cognitive or memory issues?

Yes, official adverse event reports mention potential issues affecting the nervous system, which include memory problems, confusion, and thinking abnormality. These cognitive effects may be more pronounced in older adults and children.


Q: Are there different strengths or formulations of Phenotal?

Phenotal (phenobarbital) is available in several forms to suit different patient needs. These include oral tablets, an oral solution (elixir), and a solution for injection. All of these forms are manufactured in various strengths.


Q: Does Phenotal interact with birth control pills?

Yes, regulatory information explicitly warns that Phenotal can make hormonal contraceptives (like birth control pills, patches, or rings) less effective. This is because the drug accelerates the breakdown of the hormones in the liver. Regulatory guidance often states that alternative or backup barrier methods of contraception are necessary while taking this medication.


Q: Can Phenotal make other medications work differently?

Yes, Phenotal is a potent enzyme inducer, meaning it speeds up the rate at which the liver processes many other drugs. This can lower the blood levels of other medications—including certain antibiotics, blood thinners (anticoagulants), and hormones—potentially reducing their intended therapeutic effect.


Q: Is Phenotal known to cause skin reactions or rashes?

Yes, Phenotal has been associated with severe dermatologic reactions, which are serious but rare. These include life-threatening conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Other less severe rashes, fever, or blistering have also been reported in official documents.


Q: How often is Phenotal usually taken?

For maintenance therapy, the official labeling permits the medication to be taken either once daily—often at bedtime—or to have the total daily amount divided into two or three doses throughout the day.


Q: Can taking Phenotal affect my driving ability?

Official warnings indicate that Phenotal may impair the mental and physical abilities required for tasks such as driving a car or operating heavy machinery. Official warnings note that caution is advised until the patient is aware of the medication’s effects.


Q: Are there different brands of Phenotal available?

Phenotal is the trade name for the active ingredient phenobarbital. Since phenobarbital is a widely used and older medication, lower-cost, generic versions of phenobarbital are generally available.

How should Phenotal be stored and disposed of?

Official Storage Requirements

Phenotal (phenobarbital) must be stored according to strict regulatory guidelines to maintain its stability and integrity. The medication requires storage at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with protection from both light and moisture.

Keep the product in its original, tightly closed, light-resistant container. Any liquid or reconstituted forms have specific stability limitations and must be discarded if unused after the defined short period (e.g., 8–24 hours).

Child Safety and Disposal

As a Schedule IV controlled substance, Phenotal must be stored in a secure location and kept out of the sight and reach of children using a child-resistant closure.

Disposal of unused or expired product should follow official guidance, ideally through a drug take-back program. When such programs are unavailable, disposal must be done in a secure manner according to local regulations, mixing the medicine with an undesirable substance before discarding in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Phenotal found in:

A-Z Index: